DOI: 10.1055/s-00000036

Laryngo-Rhino-Otologie

References

Curti BD, Kovacsovics-Bankowski M, Morris N. et al.
OX40 is a potent immune-stimulating target in late-stage cancer patients.

Cancer Res 2013;
73: 7189-7198

Download Bibliographical Data

Search in:
Access: